Nicholas A.J. Botwood

Insider Reports History

Location
New York, NY
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicholas A.J. Botwood:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Head of R&D, CMO Common Stock 35,165 $316,309 $9.00 16 May 2025 Direct

Insider Reports Filed by Nicholas A.J. Botwood

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNDX Syndax Pharmaceuticals Inc 16 May 2025 1 +$105,826 4 Head of R&D, CMO 19 May 2025, 16:03
SNDX Syndax Pharmaceuticals Inc 12 May 2025 0 $0 3 Head of R&D, CMO 16 May 2025, 16:16